Yan Lavrovsky

2.9k total citations
39 papers, 2.2k citations indexed

About

Yan Lavrovsky is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Yan Lavrovsky has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Yan Lavrovsky's work include Heme Oxygenase-1 and Carbon Monoxide (6 papers), DNA and Nucleic Acid Chemistry (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Yan Lavrovsky is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (6 papers), DNA and Nucleic Acid Chemistry (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Yan Lavrovsky collaborates with scholars based in United States, Russia and United Kingdom. Yan Lavrovsky's co-authors include Nader G. Abraham, Michal L. Schwartzman, Arun K. Roy, Attallah Kappas, R D Levere, Chung S. Song, Bandana Chatterjee, Robert A. Stoltz, Rakesh K. Tyagi and Soon‐Cheol Ahn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of the American College of Cardiology.

In The Last Decade

Yan Lavrovsky

38 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Lavrovsky United States 19 1.5k 378 284 228 214 39 2.2k
Susan P. LeDoux United States 41 3.2k 2.2× 314 0.8× 222 0.8× 213 0.9× 181 0.8× 68 4.6k
Kensuke Murakami Japan 23 1.2k 0.8× 103 0.3× 110 0.4× 141 0.6× 117 0.5× 76 2.7k
Ling He United States 28 2.0k 1.4× 221 0.6× 156 0.5× 669 2.9× 148 0.7× 64 3.8k
Stephen A. Kempson United States 26 868 0.6× 207 0.5× 237 0.8× 144 0.6× 225 1.1× 92 2.1k
Larry Denner United States 35 1.8k 1.2× 665 1.8× 184 0.6× 519 2.3× 156 0.7× 71 3.6k
Ana Paula Dantas Spain 30 734 0.5× 315 0.8× 178 0.6× 480 2.1× 118 0.6× 89 2.5k
Shouyin Di China 36 1.4k 0.9× 61 0.2× 219 0.8× 116 0.5× 185 0.9× 53 2.9k
Thomas W. Honeyman United States 28 1.3k 0.9× 191 0.5× 771 2.7× 187 0.8× 195 0.9× 73 2.4k
Carmelo Muià Italy 34 765 0.5× 176 0.5× 165 0.6× 85 0.4× 66 0.3× 64 2.6k
E. L. Hogan United States 28 1.1k 0.7× 103 0.3× 117 0.4× 75 0.3× 408 1.9× 65 2.7k

Countries citing papers authored by Yan Lavrovsky

Since Specialization
Citations

This map shows the geographic impact of Yan Lavrovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Lavrovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Lavrovsky more than expected).

Fields of papers citing papers by Yan Lavrovsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Lavrovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Lavrovsky. The network helps show where Yan Lavrovsky may publish in the future.

Co-authorship network of co-authors of Yan Lavrovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Lavrovsky. A scholar is included among the top collaborators of Yan Lavrovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Lavrovsky. Yan Lavrovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abbate, Antonio, Benjamín Van Tassell, Vladimir Bogin, et al.. (2024). Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study. Journal of Cardiovascular Pharmacology. 84(6). 565–577. 7 indexed citations
2.
Моисеева, О. М., et al.. (2023). Treatment of Idiopathic Recurrent Pericarditis With Goflikicept. Journal of the American College of Cardiology. 82(1). 30–40. 38 indexed citations
3.
Куликов, А. В., Colin P. Guy, J. Stanley Smith, et al.. (2021). Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120. Frontiers in Pharmacology. 12. 723038–723038. 5 indexed citations
4.
5.
Krasavin, Mikhail, et al.. (2010). Discovery and SAR exploration of N-aryl-N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents for prostate cancer. Chemistry Central Journal. 4(1). 4–4. 14 indexed citations
6.
Ivanenkov, Yan A., Konstantin V. Balakin, & Yan Lavrovsky. (2010). Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics. Mini-Reviews in Medicinal Chemistry. 11(1). 55–78. 81 indexed citations
7.
Krasavin, Mikhail, Рубен Карапетян, I. O. Konstantinov, et al.. (2009). Discovery and Potency Optimization of 2‐Amino‐5‐arylmethyl‐1,3‐thiazole Derivatives as Potential Therapeutic Agents for Prostate Cancer. Archiv der Pharmazie. 342(7). 420–427. 18 indexed citations
8.
Lavrovsky, Yan, et al.. (2008). CXCR4 Receptor as a Promising Target for Oncolytic Drugs. Mini-Reviews in Medicinal Chemistry. 8(11). 1075–1087. 7 indexed citations
9.
Lavrovsky, Yan, Chung S. Song, Bandana Chatterjee, & Arun K. Roy. (2000). Age-dependent increase of heme oxygenase–1 gene expression in the liver mediated by NFκB. Mechanisms of Ageing and Development. 114(1). 49–60. 74 indexed citations
10.
Roy, Arun K., Yan Lavrovsky, Cuidan Song, et al.. (1998). Regulation of Androgen Action. Vitamins and hormones. 55. 309–352. 239 indexed citations
11.
Chen, Shuo, Chung S. Song, Yan Lavrovsky, et al.. (1998). Catalytic Cleavage of the Androgen Receptor Messenger RNA and Functional Inhibition of Androgen Receptor Activity by a Hammerhead Ribozyme. Molecular Endocrinology. 12(10). 1558–1566. 41 indexed citations
12.
Lavrovsky, Yan, et al.. (1998). A Rapid and Reliable PCR-based Assay for Gene Transmission and Sex Determination in Newborn Transgenic Mice. Transgenic Research. 7(4). 319–320. 17 indexed citations
13.
Lavrovsky, Yan, Shuo Chen, & Arun K. Roy. (1997). Therapeutic Potential and Mechanism of Action of Oligonucleotides and Ribozymes. Biochemical and Molecular Medicine. 62(1). 11–22. 18 indexed citations
14.
Lavrovsky, Yan, Vladimir Mastyugin, Robert A. Stoltz, & Nader G. Abraham. (1996). Specific inhibition of c-fos proto-oncogene expression by triple-helix-forming oligonucleotides. Journal of Cellular Biochemistry. 61(2). 301–309. 7 indexed citations
15.
Lavrovsky, Yan, Vladimir Mastyugin, Robert A. Stoltz, & Nader G. Abraham. (1996). Specific inhibition of c‐fos proto‐oncogene expression by triple‐helix‐forming oligonucleotides. Journal of Cellular Biochemistry. 61(2). 301–309. 2 indexed citations
16.
Lavrovsky, Yan, Robert A. Stoltz, Valentin V. Vlassov, & Nader G. Abraham. (1996). c‐fos Protooncogene Transcription can be Modulated by Oligonucleotide‐Mediated Formation of Triplex Structures in vitro. European Journal of Biochemistry. 238(2). 582–590. 11 indexed citations
17.
Lavrovsky, Yan, et al.. (1994). The reversion of highly tumorigenic cell lines to non‐tumorigenic phenotype is associated with c‐jun down‐expression. FEBS Letters. 356(2-3). 212–214. 2 indexed citations
18.
Lavrovsky, Yan, et al.. (1994). Characterization of a 142-bp fragment of the murine c-fos oncogene promoter upstream of the SIF-binding element. Gene. 142(2). 285–290. 8 indexed citations
19.
Lavrovsky, Yan, et al.. (1993). c‐fos gene expression in cell revertants from a transformed to a pseudonormal phenotype. FEBS Letters. 316(2). 161–164. 6 indexed citations
20.
Guvakova, Marina A., et al.. (1992). High frequency of tumour cell reversion to non-tumorigenic phenotype. European Journal of Cancer. 28(1). 17–21. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan P. LeDoux Breakdown of academic impact, for papers by Kensuke Murakami Breakdown of academic impact, for papers by Ling He Breakdown of academic impact, for papers by Stephen A. Kempson Breakdown of academic impact, for papers by Larry Denner Breakdown of academic impact, for papers by Ana Paula Dantas Breakdown of academic impact, for papers by Shouyin Di Breakdown of academic impact, for papers by Thomas W. Honeyman Breakdown of academic impact, for papers by Carmelo Muià Breakdown of academic impact, for papers by E. L. Hogan
Rankless by CCL
2026